Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

NCT06955104 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: JW0108 + C2407
DRUG: JW0108 + C2407 placebo

Sponsor

JW Pharmaceutical